These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 16107144)

  • 1. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
    Radestock S; Weil T; Renner S
    J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PREDICT modeling and in-silico screening for G-protein coupled receptors.
    Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
    Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-ligand-based virtual screening: methods and applications of the MTree approach.
    Hessler G; Zimmermann M; Matter H; Evers A; Naumann T; Lengauer T; Rarey M
    J Med Chem; 2005 Oct; 48(21):6575-84. PubMed ID: 16220974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-based structural hypotheses for virtual screening.
    Jain AN
    J Med Chem; 2004 Feb; 47(4):947-61. PubMed ID: 14761196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor.
    Evers A; Klabunde T
    J Med Chem; 2005 Feb; 48(4):1088-97. PubMed ID: 15715476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects.
    Klabunde T; Evers A
    Chembiochem; 2005 May; 6(5):876-89. PubMed ID: 15791686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug design strategies for targeting G-protein-coupled receptors.
    Klabunde T; Hessler G
    Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods.
    Bissantz C; Schalon C; Guba W; Stahl M
    Proteins; 2005 Dec; 61(4):938-52. PubMed ID: 16224780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPCR structure-based virtual screening approach for CB2 antagonist search.
    Chen JZ; Wang J; Xie XQ
    J Chem Inf Model; 2007; 47(4):1626-37. PubMed ID: 17580929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding ligands for G protein-coupled receptors based on the protein-compound affinity matrix.
    Fukunishi Y; Kubota S; Nakamura H
    J Mol Graph Model; 2007 Jan; 25(5):633-43. PubMed ID: 16777448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of structure- and ligand-based virtual screening protocols considering hit list complementarity and enrichment factors.
    Krüger DM; Evers A
    ChemMedChem; 2010 Jan; 5(1):148-58. PubMed ID: 19908272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screen for ligands of orphan G protein-coupled receptors.
    Bock JR; Gough DA
    J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring.
    Zhang Q; Muegge I
    J Med Chem; 2006 Mar; 49(5):1536-48. PubMed ID: 16509572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
    Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
    J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation.
    Askjaer S; Langgård M
    J Chem Inf Model; 2008 Mar; 48(3):476-88. PubMed ID: 18281962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.